Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-27

Clinical Trial Update: Smoking Relapse Prevention in Schizophrenia [Phase 4]

View source ↗

Summary

This clinical trial update reports a Phase 4 study on preventing smoking relapse in individuals with schizophrenia or schizoaffective disorder, which has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED